Generic name |
vedolizumab |
|
---|---|---|
Strength |
300 mg/vial |
108 mg/0.68 mL |
Form |
solution for infusion |
single-use pre-filled pen |
Special Authority criteria |
Approval period |
---|---|
Moderate to severe active Crohn's disease, according to established criteria, when prescribed by a gastroenterologist |
First approval (induction period): 3 doses Renewal: 1 year |
Moderate to severe ulcerative colitis, according to established criteria, when prescribed by a gastroenterologist. |
First approval (induction period): 3 doses Renewal: 1 year |
Crohn's disease
Ulcerative colitis